Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total transaction of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The shares were sold at an average price of $8.47, for a total value of $18,693.29. Following the sale, the director now directly owns 28,826 shares in the company, valued […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) CFO Robert Andrade sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $8.99, for a total value of $89,900.00. Following the transaction, the chief financial officer now directly owns 139,721 shares in the company, […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) CFO Robert Andrade sold 10,000 shares of Fennec Pharmaceuticals stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $8.99, for a total transaction of $89,900.00. Following the completion of the transaction, the chief financial officer now owns 139,721 shares in […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,720,000 shares, an increase of 17.0% from the May 15th total of 1,470,000 shares. Approximately 7.9% of the shares of the stock are sold […]